Results 181 to 190 of about 788,725 (322)

Medical disputes involving lower gastrointestinal endoscopies: cases from the Korean Medical Dispute Mediation and Arbitration Agency. [PDF]

Korean J Intern Med
Oh EH, Shin JE, Bae JY, Lee YS, Park Y, Kwon YH, Paik CN, Lee JK, Lee TH.   +8 more
europepmc   +1 more source

Administrative Mediation in Environmental Disputes

2017 4th International Conference on Business, Economics and Management (BUSEM 2017), 2017
openaire   +1 more source

Quo Vadis Object of Civil Court of Justice Disputes After Government Administrative Law : Regional House of People’s Representative Decision Concerning Dismissal Recomendation for Regional Chief/Vice Chief

, 2020
Nur Sayekti, Isharyanto Isharyanto
openalex   +2 more sources

Perfecting the Administrative Solution to Labour Disputes: Postscript [PDF]

, 2005
Philip A. Joseph
openalex   +1 more source

Frailty Exacerbates Disability in Progressive Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks, Anna Wolska, Diala Ghazal, Dejan Jakimovski, Bianca Weinstock‐Guttman, Alexander Burnham, Niels Bergsland, Michael G. Dwyer, Alan T. Remaley, Robert Zivadinov, Murali Ramanathan   +10 more
wiley   +1 more source

From Guidance to Grievance: Postgraduates, Mentors, and the Authorship Dispute. [PDF]

J Orthop Case Rep
Pai SN, Jeyaraman M, Jeyaraman N, Shyam A.   +3 more
europepmc   +1 more source

MODERN VIEW OF TAX DISPUTES AS A SUBJECT OF ADMINISTRATIVE JURISDICTION

, 2023
O.Ye. Demenko
openalex   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

The New Path Forward for Prior Authorizations: Navigating Differences in the Accepted Standards of Care, Society Guidelines, and FDA-approved Indications. [PDF]

Open Forum Infect Dis
Desai AN, Rauseo A, Rogan GN, Spec A, Thompson GR.   +4 more
europepmc   +1 more source

The McCance Brain Care Score and Mortality: Evidence From a Large‐Scale Population‐Based Cohort

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives This study aimed to examine the relationship between the McCance Brain Care Score (BCS) and mortality in the general population. Methods We conducted a prospective, population‐based cohort study using data from the UK Biobank. Participants with complete data enabling calculation of BCS and full mortality information were included ...
Zhiqiang Xu, Xiaoxiao Wang, Nan Li
wiley   +1 more source